Education
About Us
Working with TipRanks
Follow Us
NeoGenomics (NEO)
NASDAQ:NEO
NEO Analyst Ratings
Moderate Buy
10 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NEO Stock 12 Month Forecast
Average Price Target
$17.78
▲(88.95% Upside)
| Highest Price Target$19.00 | Average Price Target$17.78 | Lowest Price Target$16.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Piper Sandler
Reiterated
03/19/25
Craig-Hallum
Reiterated
03/18/25
BTIG
Reiterated
03/17/25
TD Cowen
Reiterated
03/11/25
William Blair
Reiterated
03/10/25
Leerink Partners
Reiterated
03/10/25
Morgan Stanley
Reiterated
02/19/25
TD Securities
Reiterated
02/19/25
Jefferies
Reiterated
02/18/25
Bank of America Securities
Reiterated
02/18/25
Raymond James
―
Hold
―
Reiterated
02/18/25
Raymond James reiterates Market Perform Rating on Neogenomics (NEO)Raymond James analyst Andrew Cooper reiterated a Market Perform on Neogenomics (NASDAQ: NEO).
Needham
$19→$18
Buy
91.29%
Upside
Reiterated
02/18/25
Buy Rating Maintained for NeoGenomics Despite Mixed Results and Leadership Changes
Goldman Sachs
$20→$18
Buy
91.29%
Upside
Reiterated
01/28/25
Neogenomics (NEO) PT Lowered to $18 at Goldman SachsGoldman Sachs analyst Matthew Sykes lowered the price target on Neogenomics (NASDAQ: NEO) to $18.00 (from $20.00) while maintaining a Buy rating.
Benchmark Co.
―
Hold
―
Reiterated
01/16/25
Benchmark Co. Sticks to Its Hold Rating for NeoGenomics (NEO)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Piper Sandler
Reiterated
03/19/25
Craig-Hallum
Reiterated
03/18/25
BTIG
Reiterated
03/17/25
TD Cowen
Reiterated
03/11/25
William Blair
Reiterated
03/10/25
Leerink Partners
Reiterated
03/10/25
Morgan Stanley
Reiterated
02/19/25
TD Securities
Reiterated
02/19/25
Jefferies
Reiterated
02/18/25
Bank of America Securities
Reiterated
02/18/25
Raymond James
―
Hold
―
Reiterated
02/18/25
Raymond James reiterates Market Perform Rating on Neogenomics (NEO)Raymond James analyst Andrew Cooper reiterated a Market Perform on Neogenomics (NASDAQ: NEO).
Needham
$19→$18
Buy
91.29%
Upside
Reiterated
02/18/25
Buy Rating Maintained for NeoGenomics Despite Mixed Results and Leadership Changes
Goldman Sachs
$20→$18
Buy
91.29%
Upside
Reiterated
01/28/25
Neogenomics (NEO) PT Lowered to $18 at Goldman SachsGoldman Sachs analyst Matthew Sykes lowered the price target on Neogenomics (NASDAQ: NEO) to $18.00 (from $20.00) while maintaining a Buy rating.
Benchmark Co.
―
Hold
―
Reiterated
01/16/25
Benchmark Co. Sticks to Its Hold Rating for NeoGenomics (NEO)
NEO Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
2
2
1
4
8
Buy
8
9
16
17
20
Hold
4
4
7
8
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
15
24
29
35
Each month's total comprises the sum of three months' worth of ratings.
NEO Financial Forecast
NEO Stock Forecast FAQ
What is NEO’s average 12-month price target, according to analysts?
Based on analyst ratings, NeoGenomics’s 12-month average price target is $17.78.
What is NEO’s upside potential, based on the analysts’ average price target?
NeoGenomics has 88.95% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NEO a Buy, Sell or Hold?
NeoGenomics has a consensus rating of Moderate Buy which is based on 10 buy ratings, 4 hold ratings and 0 sell ratings.
What is NeoGenomics’s price target?
The average price target for NeoGenomics is $17.78. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $19.00 ,the lowest forecast is $16.00. The average price target represents 88.95% Increase from the current price of $9.41.
The highest analyst price target is $19.00 ,the lowest forecast is $16.00. The average price target represents 88.95% Increase from the current price of $9.41.
What do analysts say about NeoGenomics?
NeoGenomics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of NEO?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.